Progress or Setback?

In Season 3, Episode 3 of The Cannabyss, we dive into one of the most controversial topics in cannabis policy today: the DEA’s proposal to reschedule cannabis from Schedule I to Schedule III. While some see this as a long-overdue acknowledgment of cannabis’s medical potential, others, including renowned researcher Dr. Sue Sisley, argue it could stifle progress and disproportionately benefit pharmaceutical giants. Join us as we explore the complexities of this debate, the lawsuit challenging the rescheduling process, and the potential implications for legalization, equity, and the global cannabis landscape. Don’t miss this deep dive into the future of cannabis reform!